ROBERT STAHLMAN

Allopathic & Osteopathic Physicians|Family Medicine MESQUITE, TX NPI 1679640957

General Payments — all program years on this page

$4,924.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 253
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $280.34 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $280.3416

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,099.6957
2019 $1,468.6263
2020 $1,208.3866
2021 $635.1136
2022 $94.816
2023 $137.339
2024 $280.3416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078209133 Janssen Pharmaceuticals, Inc $14.76 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087320969 Novartis Pharmaceuticals Corporation $30.22 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097406015 Novo Nordisk Inc $22.95 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104212815 AstraZeneca Pharmaceuticals LP $14.13 11/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104586322 AstraZeneca Pharmaceuticals LP $14.04 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104741055 AstraZeneca Pharmaceuticals LP $14.35 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105273883 AstraZeneca Pharmaceuticals LP $13.13 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106152327 ABBVIE INC. $17.65 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115951377 GlaxoSmithKline, LLC. $17.34 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118107437 Boehringer Ingelheim Pharmaceuticals, Inc. $14.26 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125189248 Abbott Laboratories $22.10 09/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131638857 PFIZER INC. $25.56 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135336865 Lilly USA, LLC $14.94 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135360310 Lilly USA, LLC $14.93 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135370240 Lilly USA, LLC $13.69 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151129459 Phathom Pharmaceuticals, Inc. $16.29 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.